4d Pharma Plc - Warrants (22/02/2025) Long Term Debt

The latest long-term debt for LBPSW is $13M as of December 2021. That compares with $990K in the prior-year period — up 1187.6% year over year. Investors often review this figure alongside 4d Pharma Plc - Warrants (22/02/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LBPSW's long-term debt moved from $990K to $13M — a 1187.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 4d Pharma Plc - Warrants (22/02/2025)'s operating scale or balance-sheet position.

A long-term debt figure of $13M for LBPSW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LBPSW's long-term debt ($13M), review year-over-year change from $990K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 4d Pharma Plc - Warrants (22/02/2025)'s long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.